ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

VAXX Vaxxinity Inc

0.115
-0.0064 (-5.27%)
27 4월(4) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Vaxxinity Inc VAXX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.0064 -5.27% 0.115 13:00:07
개장가 저가 고가 종가 전일 종가
0.121 0.1075 0.125 0.1166 0.1214
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
20/04/202407:53GLOBEVaxxinity Issues Shareholder Letter
20/04/202405:27GLOBEVaxxinity Announces Intention to Voluntarily Delist and..
28/03/202422:23GLOBEVaxxinity to Present Clinical Data at the Annual Academy of..
28/03/202405:41GLOBEVaxxinity Reports Fourth Quarter and Full-Year 2023..
08/03/202400:32GLOBEVaxxinity Announces Positive Target Engagement Data from..
16/02/202406:15EDGAR2Form 8-K - Current report
15/02/202422:00GLOBEVaxxinity’s Cholesterol Vaccine Candidate Successfully..
13/02/202422:00GLOBEVaxxinity to Present Clinical and Preclinical Pipeline Data..
13/02/202407:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/02/202407:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/01/202422:00GLOBEVaxxinity Announces Research Collaboration on Active..
18/01/202422:00GLOBEVaxxinity Announces Collaboration on Space Medicine Research..
03/01/202422:00GLOBEVaxxinity to Present at the 2024 J.P. Morgan Healthcare..
02/12/202300:30EDGAR2Form 8-K - Current report
01/12/202307:03EDGAR2Form 144 - Report of proposed sale of securities
01/12/202306:54EDGAR2Form 144 - Report of proposed sale of securities
30/11/202307:13EDGAR2Form 144 - Report of proposed sale of securities
30/11/202307:10EDGAR2Form 144 - Report of proposed sale of securities
22/11/202306:21EDGAR2Form 144 - Report of proposed sale of securities
22/11/202306:20EDGAR2Form 144 - Report of proposed sale of securities
14/11/202308:50GLOBEVaxxinity to Present at Upcoming November Medical and..
08/11/202322:30GLOBEVaxxinity Reports Third Quarter 2023 Financial Results and..
08/11/202321:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/11/202305:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202305:33EDGAR2Form 144 - Report of proposed sale of securities
05/10/202305:24EDGAR2Form 144 - Report of proposed sale of securities
29/09/202305:15EDGAR2Form 8-K - Current report
23/09/202305:16EDGAR2Form 144 - Report of proposed sale of securities
23/09/202305:12EDGAR2Form 144 - Report of proposed sale of securities
29/08/202321:00GLOBEVaxxinity to Present at Upcoming Investor Conferences in..
21/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
10/08/202321:00GLOBEVaxxinity Announces Publication of UB-311 Safety,..
09/08/202321:00GLOBEVaxxinity Reports Second Quarter 2023 Financial Results and..
09/08/202320:31EDGAR2Form S-3 - Registration statement under Securities Act of..
09/08/202320:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/07/202305:30GLOBEVaxxinity Appoints Peter Powchik, M.D., to Executive Vice..
28/07/202305:04EDGAR2Form 8-K - Current report
17/07/202321:00GLOBEVaxxinity Demonstrates Target Engagement of Toxic..
22/06/202321:00GLOBEVaxxinity Announces UB-312 Successfully Met Primary..
09/05/202321:00GLOBEVaxxinity Reports First Quarter 2023 Financial Results and..

최근 히스토리

Delayed Upgrade Clock